Are you a media representative looking for content on Bayer? This section provides news, press photos and more.
News
April 20, 2026
Not intended for UK Media
AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
April 16, 2026
Not intended for U.S. and UK Media
Phase III study results with Bayer’s FXIa inhibitor demonstrating substantial reduction in ischemic stroke with no increase in ISTH major bleeding versus placebo published in New England Journal of Medicine
April 01, 2026
Not intended for U.S. and UK Media
Bayer’s strongest-ever pharma portfolio and promising pipeline drive future growth
In Focus
Our Services
Publications
Get easy access to the different reports, magazines and brochures from Bayer.
Publikationen
Discover more
